Related Experiment Video
Updated: Nov 5, 2025

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
MiR-448-5p/VEGFA Axis Protects Cardiomyocytes from Hypoxia Through Regulating the FAS/FAS-L Signaling Pathway
Hanqing Tang1, Shitian Zhang1, Cenhan Huang1
1School of Basic Medicine, Youjiang Medical University for Nationalities.
Abstract:
Bioinformatics analysis showed that miR-448-5p expression in the myocardial tissue of rats with myocardial infarction significantly increased, suggesting that it may participate in myocardial cell apoptosis in myocardial infarction. This study aimed to explore the protective effects of miR-448-5p on hypoxic myocardial cells.H9C2 cells were cultured and subjected to anoxia for 2, 4, and 8 hours to establish a hypoxia model. MiR-448-5p mimic and inhibitor were transfected into the cells; then, a dual-luciferase experiment was conducted to verify the targeting relationship between miR-448-5p and VEGFA. Cell viability and apoptosis was detected by cell counting kit-8 and flow cytometry, respectively. The expressions of apoptosis-related proteins, miR-448-5p, FAS, and FAS-L were measured using western blotting and quantitative reverse transcription-polymerase chain reaction (qRT-PCR).Hypoxia-reduced H9C2 cell viability and promoted apoptosis. MiR-448-5p expression was increased after H9C2 cell hypoxia. MiR-448-5p mimic significantly inhibited the viability and promoted the apoptosis of hypoxia-induced model cells. Hypoxia promoted the expression of apoptosis-related protein B-cell lymphoma-2 (Bcl-2) and inhibited the expressions of Bcl-2-associated x protein (Bax), cleaved caspase-3, and caspase-3, whereas the effect of inhibitor on hypoxia-reduced H9C2 cell and apoptotic protein expression were opposite to miR-448-5p mimic. MiR-448-5p targeted VEGFA and regulated its expression. Silenced VEGFA expression significantly inhibited inhibitor effect on increasing cell viability and promoted apoptosis. In addition, miR-448-5p mimic inhibited the effect of hypoxia on promoting the expressions of FAS and FAS-L of H9C2 cells. Inhibitors had the opposite effect on cell hypoxia model.The miR-448-5p/VEGFA axis could protect cardiomyocytes from hypoxia through inhibiting the FAS/FAS-L signaling pathway.
Insights
MicroRNA-448-5p protects heart cells from hypoxia by targeting VEGFA and inhibiting the FAS/FAS-L pathway, reducing apoptosis and improving cell viability in myocardial infarction models.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Biochemistry
Background:
- Myocardial infarction involves significant myocardial cell apoptosis.
- MicroRNA-448-5p (miR-448-5p) expression increases in myocardial infarction, suggesting a role in apoptosis.
- The protective role of miR-448-5p in hypoxic cardiomyocytes requires elucidation.
Purpose of the Study:
- To investigate the protective effects of miR-448-5p on cardiomyocytes under hypoxic conditions.
- To explore the molecular mechanisms underlying miR-448-5p's action, including its targets and signaling pathways.
Main Methods:
- Establishment of a hypoxia model using H9C2 cells subjected to anoxia.
- Transfection with miR-448-5p mimic and inhibitor to modulate its expression.
- Dual-luciferase assay to confirm miR-448-5p targeting of VEGFA.
- Assessment of cell viability (CCK-8 assay) and apoptosis (flow cytometry).
- Measurement of apoptosis-related proteins (Bcl-2, Bax, cleaved caspase-3) and FAS/FAS-L via Western blotting and qRT-PCR.
Main Results:
- Hypoxia reduced H9C2 cell viability and increased apoptosis.
- miR-448-5p mimic counteracted hypoxia-induced apoptosis and cell death, while the inhibitor exacerbated these effects.
- miR-448-5p directly targeted VEGFA, and its mimic inhibited hypoxia-induced increases in FAS and FAS-L expression.
Conclusions:
- The miR-448-5p/VEGFA axis plays a crucial protective role in cardiomyocytes against hypoxia.
- This protection is mediated by the inhibition of the FAS/FAS-L signaling pathway.
- miR-448-5p represents a potential therapeutic target for myocardial infarction.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway
MAPK Signaling Cascades
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mechanism of Angiogenesis

